POLG1-related and other "mitochondrial Parkinsonisms": an overview

Area of Science:

• Neuroscience
• Genetics
• Mitochondrial Biology

Background:

• Mitochondrial dysfunction is increasingly recognized in sporadic Parkinson disease pathogenesis.
• Mutations in the polymerase gamma (POLG1) gene and mitochondrial DNA (mtDNA) rearrangements can directly cause parkinsonism.
• Clinical presentation of mitochondrial parkinsonism can overlap with idiopathic Parkinson disease, including ptosis, myopathy, and neuropathy.

Purpose of the Study:

• To review POLG1-related parkinsonism and other defined forms of mitochondrial parkinsonism.
• To discuss the diagnostic challenges and approaches for patients with parkinsonism and suspected mitochondrial disorders.
• To highlight that a negative family history does not exclude mitochondrial disease.

Main Methods:

• Literature review focusing on POLG1 gene mutations and mtDNA abnormalities associated with parkinsonism.
• Analysis of clinical features distinguishing mitochondrial parkinsonism from idiopathic Parkinson disease.
• Exploration of diagnostic strategies for suspected mitochondrial parkinsonism.

Main Results:

• Primary genetic abnormalities or secondary rearrangements in mtDNA, often due to POLG1 mutations, are established causes of parkinsonism.
• Mitochondrial parkinsonisms lack unique diagnostic features, complicating clinical identification.
• The study reviews specific genetic causes and clinical presentations of mitochondrial parkinsonisms.

Conclusions:

• POLG1 mutations and mtDNA alterations represent significant causes of mitochondrial parkinsonism.
• A high index of suspicion and targeted diagnostic approaches are necessary for identifying mitochondrial parkinsonism.
• Further research into diagnostic algorithms for mitochondrial parkinsonism is warranted.